672931-28-1

Basic information

• Product Name: 5-Methoxy-2-fluorobenzyl cyanide
• Synonyms: Benzeneacetonitrile, 2-fluoro-5-methoxy- (9CI);2-Fluoro-5-methoxybenzeneacetonitrile;2-(2-fluoro-5-Methoxyphenyl)acetonitrile;2-Fluoro-5-methoxybenzyl cyanide, (2-Fluoro-5-methoxyphenyl)acetonitrile;2-Fluoro-5-methoxyphenylacetonitrile 97%;2-Fluoro-5-methoxyphenylacetonitrile97%
• CAS NO: 672931-28-1
• Molecular Formula: C₉H₈FNO
• Molecular Weight: 165.1643232
• Product Categories: METHOXY;HALIDE;Fluorine series
• Mol File: 672931-28-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 279℃
• Flash Point: 122℃
• Appearance: /
• Density: 1.148
• Vapor Pressure: 0.00421mmHg at 25°C
• Refractive Index: 1.501
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 5-Methoxy-2-fluorobenzyl cyanide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Methoxy-2-fluorobenzyl cyanide(672931-28-1)
• EPA Substance Registry System: 5-Methoxy-2-fluorobenzyl cyanide(672931-28-1)

Safety Data

• Hazardous Substances Data: 672931-28-1(Hazardous Substances Data)

Usage

General Description

5-Methoxy-2-fluorobenzyl cyanide is a chemical compound with the molecular formula C9H8NOF. It is a cyanide derivative with a methoxy group and a fluorine atom attached to a benzyl group. 5-Methoxy-2-fluorobenzyl cyanide may have potential applications in the pharmaceutical and agrochemical industries, as well as in the synthesis of other organic compounds. Its properties and uses may also be of interest in the field of research and development for new materials and substances. However, it is important to handle this substance with caution as cyanide compounds are known to be highly toxic and should be used with proper safety measures in place.

InChI:InChI=1/C9H8FNO/c1-12-8-2-3-9(10)7(6-8)4-5-11/h2-3,6H,4H2,1H3

Upstream product

• 38622-91-2 [(p-methylphenyl)sulfonylmethyl]isonitrile 
• 105728-90-3 2-fluoro-5-methoxybenzaldehyde 
• 161643-29-4 (2-fluoro-5-methoxyphenyl)methanol 
• 96826-42-5 methyl 2-fluoro-5-methoxybenzoate 
• 51446-30-1 2-fluoro-5-hydroxybenzoic acid 
• 773837-37-9 sodium cyanide 
• 91319-42-5 2-(bromomethyl)-1-fluoro-4-methoxybenzene 

Downstream Products

• 1588424-23-0 7-chloro-1-ethyl-3-(2-fluoro-5-methoxyphenyl)-1,6-naphthyridin-2(1H)-one 
• 1588424-22-9 7-chloro-1-ethyl-3-(2-fluoro-5-methoxyphenyl)-1,6-naphthyridin-2(1H)-imine 
• 1359840-74-6 2-(2-fluoro-5-hydroxyphenyl)-3-phenylpropionitrile 
• 1359840-73-5 2-(2-fluoro-5-methoxyphenyl)-3-phenylpropionitrile 
• 1359840-78-0 1-methyl-1H-imidazole-4-sulfonic acid {2-[3-(2-amino-1-benzylethyl)-4-fluorophenoxy]ethyl}amide 
• 1359840-77-9 1-methyl-1H-imidazole-4-sulfonic acid {2-[3-(benzylcyanomethyl)-4-fluorophenoxy]ethyl}amide 
• 1359840-76-8 2-[5-(2-aminoethoxy)-2-fluorophenyl]-3-phenylpropionotrile 
• 1359840-75-7 {2-[3-(enzylcyanomethyl)-4-fluorophenoxy]ethyl}carbamic acid tert-butyl ester 
• 798563-50-5 2-(2-fluoro-5-methoxyphenyl)acetic acid 

Relevant articles and documents

Fluorine substituted methoxyphenylalkyl amides as potent melatonin receptor agonists?

A series of fluorine substituted methoxyphenylalkyl amides were prepared with different orientations of the fluorine and methoxy groups with respect to the alkylamide side chain and with alkyl sides of differing lengths (n = 1-3). β-Dimethyl and α-methyl

FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF

The present invention provides a compound represented by the formula (I): [wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, p is 0, 1 or 2, and when p is 2, each R may be the same or different, R1 is a hydrogen atom or an optionally substituted hydrocarbon group, R2 is an optionally substituted aromatic group, Ring A is an optionally substituted monocyclic aromatic ring or optionally substituted bicyclic aromatic fused ring, X1 is an oxygen atom or a sulfur atom, X2 is a bond, an oxygen atom or -S(O)n- (wherein n is 0, 1 or 2), Y is a bond, an oxygen atom, -S(O)m-, -C(=O)-N(R3)- or -N(R3)-C(=O)- (R3 is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, and m is 0, 1 or 2), M1, M2 and M3 may be the same or different and are each independently a bond or an optionally substituted divalent aliphatic hydrocarbon group, and M4 is an optionally substituted divalent aliphatic hydrocarbon group] or a salt thereof, which is useful as a prophylactic and/or therapeutic agent for lipid metabolism abnormality, arteriosclerotic disease and sequelae thereof, diabetes mellitus and the like.